HeshamYasinMD

PubMed

• Artificial intelligence modelling to assess the risk of cardiovascular disease in oncology patients.
  Samer S Al-Droubi, Eiman Jahangir, Karl M Kochendorfer, Marianna Krive, Michal Laufer-Perl, Dan Gilon, Tochukwu M Okwuosa, Christopher P Gans, Joshua H Arnold, Shakthi...> ;European Heart Journal. Digital Health. 2023 Aug 1
• An international real-world analysis of relapsed/refractory lymphoma occurring during pregnancy.
  Faheem Farooq, Justin S Brandt, Elyce Cardonick, Evgeniya Polushkina, Julie Vose, Sairah Ahmed, Praveen Ramakrishnan Geethakumari, Adam J Olszewski, Hesham Yasin, Umar...> ;Blood Advances. 2023 Sep 26
• 5 citations
  The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outc...
  Yu-Wei Chen, Matthew D Tucker, Landon C Brown, Hesham A Yasin, Kristin K Ancell, Andrew J Armstrong, Kathryn E Beckermann, Nancy B Davis, Michael R Harrison, Elizabeth...> ;Cancers. 2022 Aug 7
• 3 citations
  A Rare Case of Midostaurin-Associated Sweet's Syndrome.
  Hesham Yasin, Tessa Laytem, Grerk Sutamtewagul, Sabarish Ayyappan> ;Case Reports in Hematology. 2022 Jan 1
• 3 citations
  Metastatic Renal Cell Carcinoma to the Spine: Outcomes and Morbidity: Single-Center Experience.
  Brian J. Park, Scott C. Seaman, Jennifer Noeller, Mark C. Smith, David Hasan, Hesham Yasin, Patrick W. Hitchon> ;World Neurosurgery. 2021 Jul 17
• 39 citations
  Comprehensive review of chromophobe renal cell carcinoma
  Rohan Garje, Dean Elhag, Hesham A Yasin, Luna Acharya, Daniel Vaena, Laila Dahmoush> ;Critical Reviews in Oncology/hematology. 2021 Mar 19
• 1 citations
  Avelumab in Combination with Eribulin Mesylate in Metastatic Urothelial Carcinoma: BTCRC GU-051, a Phase 1b Study.
  Monika Joshi, Sheldon L. Holder, Junjia Zhu, Hong Zheng, Shraddha Komanduri, Joshua I. Warrick, Hesham Yasin, Rohan Garje, Bei Jia, Joseph J. Drabick, David J. DeGraff...> ;European Urology Focus. 2021 Mar 17
• 44 citations
  Obesity diminishes response to PD-1-based immunotherapies in renal cancer.
  Shannon K. Boi, Rachael M. Orlandella, Justin T. Gibson, William J. Turbitt, Gal Wald, Lewis Thomas, Claire Buchta Rosean, Katlyn E Norris, Megan Bing, Laura A. Bertra...> ;Journal for Immunotherapy of Cancer. 2020 Dec 1
• 23 citations
  Fibroblast Growth Factor Receptor (FGFR) Inhibitors in Urothelial Cancer.
  Rohan Garje, Josiah An, Mohammad Obeidat, Kranthi Kumar, Hesham A Yasin, Yousef Zakharia> ;The Oncologist. 2020 Nov 1
• Join now to see all